BEDFORD, Mass., April 15, 2021 (GLOBE NEWSWIRE) — Anika Therapeutics, Inc. (NASDAQ: ANIK), a world joint preservation firm in early intervention orthopedics, immediately introduced that the Firm plans to concern its first quarter 2021 monetary outcomes after the shut of the market on Thursday, Might 6, 2021 and maintain its investor convention name on the identical day, at 5:00 p.m. ET to debate its monetary outcomes and enterprise highlights.
The convention name may be accessed by dialing 1-800-437-2398 (toll-free home) or 1-856-344-9206 (worldwide) and offering the convention ID quantity 6335822. A dwell audio webcast might be out there within the Investor Relations part of Anika’s web site, www.anika.com. An accompanying slide presentation additionally may be accessed through the Anika web site. The decision might be archived and accessible on the identical web site shortly after its conclusion.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a world joint preservation firm that creates and delivers significant developments in early intervention orthopedic care. We associate with physicians to know what they want most to deal with their sufferers and we develop minimally invasive merchandise that restore energetic residing for folks world wide. We’re dedicated to main in excessive alternative areas inside orthopedics, together with osteoarthritis ache administration, regenerative options, smooth tissue restore and bone preserving joint applied sciences. For extra info, please go to www.anika.com.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Govt Director, Investor Relations and Company Communications